Lower risk of heart failure and death in patients initiated on sodiumglucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodiumglucose cotransporter-2 inhibitors)
Justin Cole, host of DISRxUPT Podcast
This comprehensive approach to diabetes care addresses both glucose regulation and critical cardiovascular protection, making it a valuable addition to many treatment regimens
2015;7:a006080 Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al
Do not expose to sunlight or moisture
The other authors have no conflict of interests related to this publication